Welcome to our dedicated page for Donaldson news (Ticker: DCI), a resource for investors and traders seeking the latest updates and insights on Donaldson stock.
Donaldson Inc (NYSE: DCI), a global leader in filtration systems and solutions, provides critical updates through this dedicated news hub. Investors and industry professionals will find authoritative coverage of corporate developments, including earnings announcements, product innovations, and strategic partnerships.
This resource serves as a comprehensive repository for all official communications and market-relevant updates. Users can expect timely information on quarterly financial results, new filtration technology launches, and sustainability initiatives, along with analysis of operational milestones across DCI's mobile, industrial, and life sciences divisions.
Key updates include developments in advanced air/liquid purification systems, industrial equipment efficiency improvements, and cross-sector engineering collaborations. The curated content enables stakeholders to track DCI's progress in addressing complex filtration challenges through its patented technologies.
Bookmark this page for direct access to verified information about Donaldson's market leadership in engineered filtration solutions. Check regularly for updates that impact long-term value creation in essential industries from transportation to pharmaceuticals.
Donaldson Company, Inc. (NYSE: DCI) has completed its acquisition of a 49% minority stake in Medica S.p.A., a leader in hollow fiber membrane filtration technology, for approximately €62 million. This strategic move aligns with Donaldson's goal of expanding its Life Sciences business. Medica, headquartered in Medolla, Italy, specializes in medical device applications and water purification. With over 700 employees globally, Medica generated €80 million in revenue in 2023. This acquisition is expected to enhance Donaldson's capabilities in the filtration industry and strengthen its position in the life sciences sector.
Donaldson Company, Inc. (NYSE: DCI), a global leader in filtration products and solutions, has announced its upcoming fourth quarter 2024 earnings conference call. The call will be webcast on Wednesday, August 28, 2024, at 9:00 a.m. CT. Investors can access the live webcast through the 'Events & Presentations' section of Donaldson's Investor Relations website. A replay will be available from approximately 12:00 p.m. CT on the same day.
Donaldson, founded in 1915, serves a wide range of industries and advanced markets through its three primary segments: Mobile Solutions, Industrial Solutions, and Life Sciences. The company operates in over 140 locations across six continents, partnering with diverse customers from small business owners to major OEM brands.
Donaldson Company, Inc. (NYSE: DCI), a global leader in filtration products and solutions, has announced a regular cash dividend of 27.0 cents per share. The dividend is payable on August 28, 2024, to shareholders of record on August 13, 2024. This declaration marks Donaldson's 68th consecutive year of quarterly cash dividends and its 28th consecutive year of annual dividend increases as of 2023. Donaldson is a member of the S&P High-Yield Dividend Aristocrats Index, reflecting its consistent dividend growth. The company, founded in 1915, operates through three primary segments: Mobile Solutions, Industrial Solutions, and Life Sciences, serving diverse industries and advanced markets globally.
Donaldson Company, Inc. (NYSE:DCI) has announced that DonorsChoose, an education equity organization, is the recipient of the Donaldson Foundation $100K Challenge grant. This year's theme focused on childhood education. The grant will be used to match donations made by the public for DonorsChoose projects in communities where Donaldson operates in the United States, effectively doubling the impact.
DonorsChoose was selected through a voting process involving Donaldson's U.S.-based employees. Two other finalists, Little Free Library and United Through Reading, will each receive $10,000 to support their missions. In fiscal year 2023, the Donaldson Foundation distributed $1.2 million to nonprofit organizations, emphasizing its commitment to supporting education initiatives and strengthening communities.
Donaldson's Univercells Technologies business has expanded its evaluation agreement with the Gene Therapy Program (GTP) at the University of Pennsylvania. The collaboration aims to assess the scalability of gene therapy production using Univercells Technologies' bioreactors, specifically the scale-X™ nitro 600 m2 bioreactor. This partnership seeks to increase production per batch and potentially reduce cost of goods sold (COGS) for gene therapies.
The agreement highlights the importance of industry-academic partnerships in advancing gene therapy development and commercialization. Univercells Technologies' bioreactor, initially developed with support from the Bill and Melinda Gates Foundation, is now being applied to enhance viral vector accessibility for gene therapies. This collaboration aligns with GTP's vision of making gene therapies for rare diseases more accessible worldwide.
Donaldson Company (NYSE: DCI), a leading global provider of filtration solutions, has announced key leadership changes effective August 1, 2024. Andrew Dahlgren, currently President of Life Sciences, will become President of Mobile Solutions. Richard Lewis, currently President of Mobile Solutions, will take over as President of Life Sciences. These changes support Donaldson's strategic initiatives and organizational development goals, aiming toward fiscal 2026 financial targets and 2030 sustainability ambitions. Both leaders, with extensive experience within the company, promise a seamless transition.
Donaldson (NYSE: DCI) reported record sales and earnings for Q3 FY 2024. Sales increased 6.0% year-over-year to $927.9 million. GAAP net earnings reached $113.5 million, with EPS growing by 21.7% to $0.92. Gross margin improved to 35.6%, while operating margin increased to 15.5%. Operating expenses rose due to investments in Life Sciences. Mobile Solutions and Industrial Solutions saw sales growth, but On-Road and Off-Road sales declined. Life Sciences sales surged by 24.2%, driven by Bioprocessing Equipment. Fiscal 2024 EPS guidance was raised to $3.33-$3.39. Donaldson also repurchased 1.5% of its shares for $114.0 million and paid $90.3 million in dividends.
Donaldson Company (NYSE: DCI) announced an 8.0% increase in its quarterly cash dividend, raising it from 25.0 cents to 27.0 cents per share. This dividend is payable on June 28, 2024, to shareholders of record by June 17, 2024. The company is part of the S&P High-Yield Dividend Aristocrats Index and has raised its dividend annually for 28 consecutive years. Donaldson has been paying a cash dividend every quarter for the past 68 years. Founded in 1915, Donaldson is a global leader in filtration products and solutions, serving various industries with operations in over 140 locations across six continents.
Donaldson Company (NYSE: DCI) announced that Tod Carpenter, its chairman, president, and CEO, will present at two upcoming conferences: the Stifel 2024 Cross Sector Insight Conference on June 5, 2024, at 8:10 a.m. CT, and the William Blair 44th Annual Growth Stock Conference on June 6, 2024, at 10:00 a.m. CT.
Both presentations will be webcast live and available for replay for approximately 90 days on Donaldson’s Investor Relations website. Donaldson is a global leader in filtration products and solutions, serving various industries with a focus on Mobile Solutions, Industrial Solutions, and Life Sciences.
Donaldson celebrated its 2024 patent recipients and Inventor Award winners, recognizing 100 individuals for their contributions to filtration technology. The company, with over 4,373 active patents and 190 new patents awarded last fiscal year, continues its legacy of innovation. Key awards include the Technology Achievement Award for the Hydraulic Deaeration team, Technology Champion Award to Kristoff Decoster, Emerging Innovator Award to Michael Dzuricky, Richard M. Negri Manufacturing Excellence Award to Steve Dodd, and Frank A. Donaldson Award to Ben Nelson. Donaldson remains a global leader in filtration solutions, serving diverse industries through its Mobile Solutions, Industrial Solutions, and Life Sciences segments.